✦ LIBER ✦

The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered-Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study

✍ Scribed by Eisenberg, Elon; Ogintz, Miri; Almog, Shlomo

Book ID: 126897189
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 669 KB
Volume: 28
Category: Article
ISSN: 1536-0288
DOI: 10.3109/15360288.2014.941130

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized study of the safety, pharmaco

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease

✍ Stephen Rennard,Charles Fogarty,Colin Reisner,Carlos Fernandez… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 440 KB

A Phase 1 Dose Escalation Study of the S

A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies

✍ O'Connor, O. A.; Stewart, A. K.; Vallone, M.; Molineaux, C. J.; Kunkel, L. A.; G 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 377 KB

A Phase 1 dose-escalation study of the s

A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors

✍ Shapiro, Geoffrey I.; McCallum, Stewart; Adams, Laurel M.; Sherman, Laurie; Well 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 260 KB

The Safety and Efficacy of a Single Dose

The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics in Patients with Cancer

✍ Vincent Crosby; Andrew Wilcock; Dm Mrcp; Ray Corcoran 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Analgesic efficacy and safety of the nov

Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study

✍ Ostenfeld, T.; Krishen, A.; Lai, R.Y.; Bullman, J.; Baines, A.J.; Green, J.; Ana 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 485 KB

A phase III study of the safety and effi

A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

✍ Yves Benhamou; Nezam H. Afdhal; David R. Nelson; Mitchell L. Shiffman; Deanine G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB 👁 2 views

Pegylated interferon (peg-IFN) and ribavirin (RBV) are effective in eradicating the hepatitis C virus in more than half of patients. However, anemia arising from RBV-induced hemolysis can prompt dose reductions and lower sustained virologic response (SVR) rates. In early clinical trials, Viramidine